Renal toxicities associated with pembrolizumab

Izzedine, H; Mathian, A; Champiat, S; Picard, C; Mateus, C; Routier, E; Varga, A; Malka, D; Leary, A; Michels, J; Michot, JM; Marabelle, A; Lambotte, O; Amoura, Z; Soria, JC; Kaaki, S; Quellard, N; Goujon, JM; Brocheriou, I

Izzedine, H (reprint author), Peupliers Private Hosp, Dept Nephrol, Ramsay Generale Sante, Paris, France.; Izzedine, H (reprint author), UPEC, INSERM U955, IMRB, Creteil, France.

CLINICAL KIDNEY JOURNAL, 2019; 12 (1): 81

Abstract

Objective Expanded clinical experience with patients treated by pembrolizumab has accumulated. However, renal toxicities associated with this anti-pro......

Full Text Link